Brief: Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
06/11/2025 13:51
Nov 6 (Reuters) - Cue Biopharma Inc CUE.O: CUE BIOPHARMA AND IMMUNOSCAPE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP BREAKTHROUGH CELL THERAPY APPROACH FOR SOLID TUMORS Source text: ID:nGNX413dPM Further company coverage: CUE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria